InterCure Ltd. (NASDAQ:INCR - Get Free Report)'s stock price traded up 1.9% during mid-day trading on Wednesday . The company traded as high as $1.54 and last traded at $1.57. 2,937 shares were traded during mid-day trading, a decline of 89% from the average session volume of 27,823 shares. The stock had previously closed at $1.54.
InterCure Price Performance
The business's 50 day moving average price is $1.47 and its 200-day moving average price is $1.53. The company has a quick ratio of 1.15, a current ratio of 1.78 and a debt-to-equity ratio of 0.15.
Hedge Funds Weigh In On InterCure
An institutional investor recently bought a new position in InterCure stock. Moore Capital Management LP purchased a new stake in InterCure Ltd. (NASDAQ:INCR - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 97,273 shares of the company's stock, valued at approximately $156,000. Moore Capital Management LP owned about 0.21% of InterCure as of its most recent SEC filing. Hedge funds and other institutional investors own 8.34% of the company's stock.
About InterCure
(
Get Free Report)
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Featured Articles
Before you consider InterCure, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InterCure wasn't on the list.
While InterCure currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
